BioSpace News Archive

Business

MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Diseases

MannKind Corporation and Thirona Bio, Inc. announced that they have entered into a transaction that is intended to advance the development of a novel compound with potential for multiple indications.

June 10, 2021
·
4 min read
BioMidwest

OrthoPediatrics Corp. Announces Launch of Next Generation Cannulated Screw System

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the launch of its 6.5mm/7.3mm Slipped Capital Femoral Epiphysis Cannulated Screw system.

June 10, 2021
·
2 min read
Business

Werewolf Therapeutics Reports First Quarter 2021 Financial Results

Werewolf Therapeutics, Inc. announced financial results for the quarter ended March 31, 2021.

June 10, 2021
·
6 min read
BioMidwest

Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities

Bio-Techne Corporation has partnered with Autolomous to implement a first of its kind electronic batch record system, AutoloMATETM, at Bio-Techne’s GMP cellular manufacturing center.

June 10, 2021
·
3 min read
Drug Development

CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma

CASI Pharmaceuticals, Inc. announced First-Patient-In in the Phase 1 dose escalation and expansion study of CID-103, an investigational novel anti-CD38 monoclonal antibody, in patients with previously treated, relapsed or refractory multiple myeloma.

June 10, 2021
·
3 min read
MYND Life Sciences Announces Patent Applications for Depression and Neuropsychiatric Disorder Drugs

MYND Life Sciences Inc. a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals, is pleased to announce it has filed additional provisional patents that utilize various psilocybin analogs to target clinical depression.

June 10, 2021
·
3 min read
Genetown

Seres Therapeutics to Host Virtual Investor Event on June 21, 2021

Seres Therapeutics, Inc. announced that it will host a virtual investor event focused on SER-287 and SER-301, potential new therapeutic options for ulcerative colitis on Monday, June 21, 2021 from 8:30 a.m. to 10:00 a.m. ET.

June 10, 2021
·
4 min read
Drug Development

Kurome Therapeutics Closes $15 Million Series A Financing to Develop Targeted Kinase Inhibitors for Treatment of Hematopoietic Cancers

Financing Co-led by Medicxi and Affinity Asset Advisors. Funding to Advance IRAK1/4 Inhibitor Platform Through IND-Enabling Studies.

June 10, 2021
·
3 min read
Lone Star Bio

Plus Therapeutics Presents at the Sixth Biennial Pediatric Neuro-Oncology Research Conference

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company, today announced it will present a poster at the 6th Biennial Pediatric Neuro-Oncology Research Conference hosted by the Society for Neuro-Oncology (SNO), being held virtually June 10-12, 2021.

June 10, 2021
·
5 min read
Genetown

Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference

Kaleido Biosciences, Inc. today announced that CEO Dan Menichella will deliver a corporate presentation at the JMP Securities Life Sciences Conference at 4PM ET on Thursday, June 17.

June 10, 2021
·
1 min read